MeSH D015352 - dry eye syndromes
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Bausch Health Companies | Lifitegrast | Xiidra | 2024-11-05 | 2016-07-11 | ||
| Micro Laboratories | Lifitegrast | Lifitegrast | 2023-08-04 | |||
| Eugia Pharma Specialties | Lifitegrast | Lifitegrast | 2023-11-07 | |||
| Ingenus | Lifitegrast | Lifitegrast | 2024-10-03 |
Clinical Trials
Historical Success Rate
Phase 1
56%15/27
Phase 2
67%31/46
Phase 3
63%27/43
Approved: 3Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use